Clinical Trials Logo

Clinical Trial Summary

Participants had randomly divided into two equal groups. Group (A) which is the study group will receive photobiomodulation session two times per week for four weeks. Group (B) will be the control group that will receive placebo photobiomodulation two times per week for four weeks.


Clinical Trial Description

group (A): 1. Each participant will sign a consent form after receiving a detailed explanation about the procedure. 2. submaximal exercise capacity using time up and go test will be assessed. 3. fatigability will be assessed using fatigue assessment scale. 4. hemodynamic variables including; Blood pressure, heart rate, oxygen saturation, maximum oxygen consumption will also be assessed. 5. After one month all the assessment procedure will be repeated again. r group (B): 1. Each participant will sign a consent form after receiving a detailed explanation about the procedure. 2. submaximal exercise capacity using time up and go test will be assessed. 3. fatigability will be assessed using fatigue assessment scale. 4. hemodynamic variables including; Blood pressure, heart rate, oxygen saturation, maximum oxygen consumption will also be assessed. 5. After one month all the assessment procedure will be repeated again. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05094726
Study type Interventional
Source Cairo University
Contact Rana H El Banna, PHD
Phone 00201062070686
Email rana.elbanna@yahoo.com
Status Recruiting
Phase N/A
Start date September 8, 2021
Completion date November 15, 2021